KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Change in Inventory: 2018-2024

Historic Change in Inventory for Castle Biosciences (CSTL) over the last 7 years, with Dec 2024 value amounting to $193,000.

  • Castle Biosciences' Change in Inventory rose 121.30% to $307,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 161.64%. This contributed to the annual value of $193,000 for FY2024, which is 95.13% down from last year.
  • According to the latest figures from FY2024, Castle Biosciences' Change in Inventory is $193,000, which was down 95.13% from $4.0 million recorded in FY2023.
  • Castle Biosciences' Change in Inventory's 5-year high stood at $4.0 million during FY2023, with a 5-year trough of -$327,000 in FY2021.
  • Its 3-year average for Change in Inventory is $1.9 million, with a median of $1.7 million in 2022.
  • As far as peak fluctuations go, Castle Biosciences' Change in Inventory plummeted by 133.37% in 2021, and later spiked by 613.76% in 2022.
  • Over the past 5 years, Castle Biosciences' Change in Inventory (Yearly) stood at $980,000 in 2020, then tumbled by 133.37% to -$327,000 in 2021, then spiked by 613.76% to $1.7 million in 2022, then soared by 135.83% to $4.0 million in 2023, then plummeted by 95.13% to $193,000 in 2024.